吸入暴露与间歇性肺病风险相关:系统性审查和元分析
Cathryn T Lee1, Sheiphali A Gandhi2, Seham Elmrayed3
1Department of Medicine, The University of Chicago, Chicago, Illinois, USA cathryn.lee@bsd.uchicago.edu.
Thorax
|June 15, 2025
概括
这项研究确定吸烟,有机物暴露,金属,尘埃和石棉作为间歇性肺病 (ILD) 的显著吸入风险. 需要进一步的研究来探索新的职业暴露,并制定针对ILD的预防策略.
科学领域:
- 肺部医学 肺部医学
- 环境健康 环境健康
- 职业健康 职业健康 职业健康
背景情况:
- 吸入性暴露与间歇性肺病 (ILD) 风险有关.
- 各种吸入暴露和ILD之间的具体关系仍然不太清楚.
研究的目的:
- 为了确定与间歇性肺病 (ILD) 相关的吸入暴露.
- 量化这些风险对ILD风险的影响.
主要方法:
- 对MEDLINE和EMBASE数据库 (1990-2022) 的系统审查和多层次元分析.
- 排除具有确定的因果关系的ILDs (过敏性肺炎,肺结核病) 和肉类瘤.
- 包括96项研究 (超过4000万受试者) 进行审查和54项研究进行元分析.
主要成果:
- 吸烟 (OR 1.69),有机物暴露 (OR 1.56),金属 (OR 1.52),灰尘 (OR 1.45) 和石棉 (OR 1.53) 与增加ILD风险有显著的相关性.
- 和烟雾显示出积极的关联,趋向于显著.
- 分析包括了来自40490793名受试者的数据.
结论:
- 这是吸入性暴露对ILD总体风险的首次全面评估,确定了多种促成因素.
- 未来的研究应该专注于新的职业暴露,基因与环境的相互作用,以及对ILD的预防策略.
相关概念视频
01:30Pneumonia I: Introduction
345
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:20Inhalational Anesthetics: Overview
545
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
545
01:23Inhaled Medications
415
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
415